目前和新兴的射线追踪器和用于检测高级分化甲状腺癌的技术:叙述性审查
Reza Pishdad1, Prasanna Santhanam2
1Division of Endocrinology, Diabetes & Metabolism, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Cancers
|February 13, 2025
概括
差异化甲状腺癌 (DTC) 与其他甲状腺癌,如骨髓性 (MTC) 和形性 (ATC) 类型有着独特的病理特征. 了解这些差异是准确诊断和治疗策略的关键.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 内分泌学 在内分泌学.
背景情况:
- 分化甲状腺癌 (DTC),包括乳头和卵泡亚型,代表一个不同的临床病理学实体.
- 甲状腺恶性瘤表现出显著的异质性,在行为和预后方面存在显著差异.
研究的目的:
- 划出差异化甲状腺癌 (DTC) 和其他罕见的甲状腺恶性瘤之间的关键病理区别.
- 突出这些病理差异对临床管理的影响.
主要方法:
- 对DTC,状甲状腺癌 (MTC),状甲状腺癌 (ATC) 和赫特尔细胞癌的比较病理分析.
- 对诊断标准和分子标记物的审查.
主要成果:
- 与MTC,ATC和Hurthle细胞癌相比,DTC表现出独特的组织学特征和遗传改变.
- 预后影响根据特定的甲状腺癌亚型有很大差异.
结论:
- 识别各种甲状腺癌的不同病理概况对于准确诊断至关重要.
- 根据精确的组织学分类来定制治疗策略,可以改善甲状腺瘤学患者的治疗结果.
相关概念视频
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...


